SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-315383
Filing Date
2020-12-11
Accepted
2020-12-11 07:43:53
Documents
14
Period of Report
2020-12-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100861d8k.htm   iXBRL 8-K 24378
2 EX-99.1 d100861dex991.htm EX-99.1 8530
6 GRAPHIC g100861g1210205138904.jpg GRAPHIC 3078
  Complete submission text file 0001193125-20-315383.txt   159746

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20201211.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20201211_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20201211_pre.xml EX-101.PRE 10955
7 EXTRACTED XBRL INSTANCE DOCUMENT d100861d8k_htm.xml XML 3244
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 201382251
SIC: 2834 Pharmaceutical Preparations